Global Subcutaneous Allergy Immunotherapies Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
LPI (LP Information)' newest research report, the “Subcutaneous Allergy Immunotherapies Industry Forecast” looks at past sales and reviews total world Subcutaneous Allergy Immunotherapies sales in 2022, providing a comprehensive analysis by region and market sector of projected Subcutaneous Allergy Immunotherapies sales for 2023 through 2029. With Subcutaneous Allergy Immunotherapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Subcutaneous Allergy Immunotherapies industry.
This Insight Report provides a comprehensive analysis of the global Subcutaneous Allergy Immunotherapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Subcutaneous Allergy Immunotherapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Subcutaneous Allergy Immunotherapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Subcutaneous Allergy Immunotherapies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Subcutaneous Allergy Immunotherapies.
The global Subcutaneous Allergy Immunotherapies market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Subcutaneous Allergy Immunotherapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Subcutaneous Allergy Immunotherapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Subcutaneous Allergy Immunotherapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Subcutaneous Allergy Immunotherapies players cover ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, WOLW Pharma, Holister Stier and Leti, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Allergy Immunotherapies market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Subcutaneous Allergy Immunotherapies market?
What factors are driving Subcutaneous Allergy Immunotherapies market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Subcutaneous Allergy Immunotherapies market opportunities vary by end market size?
How does Subcutaneous Allergy Immunotherapies break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
LPI (LP Information)' newest research report, the “Subcutaneous Allergy Immunotherapies Industry Forecast” looks at past sales and reviews total world Subcutaneous Allergy Immunotherapies sales in 2022, providing a comprehensive analysis by region and market sector of projected Subcutaneous Allergy Immunotherapies sales for 2023 through 2029. With Subcutaneous Allergy Immunotherapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Subcutaneous Allergy Immunotherapies industry.
This Insight Report provides a comprehensive analysis of the global Subcutaneous Allergy Immunotherapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Subcutaneous Allergy Immunotherapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Subcutaneous Allergy Immunotherapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Subcutaneous Allergy Immunotherapies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Subcutaneous Allergy Immunotherapies.
The global Subcutaneous Allergy Immunotherapies market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Subcutaneous Allergy Immunotherapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Subcutaneous Allergy Immunotherapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Subcutaneous Allergy Immunotherapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Subcutaneous Allergy Immunotherapies players cover ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, WOLW Pharma, Holister Stier and Leti, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Allergy Immunotherapies market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- High Concentration
- Low Concentration
- Primary Immunodeficiency
- Secondary Immunodeficiency
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- ALK-Abello
- Stallergenes Greer
- Merck
- Allergy Therapeutics
- HAL
- WOLW Pharma
- Holister Stier
- Leti
What is the 10-year outlook for the global Subcutaneous Allergy Immunotherapies market?
What factors are driving Subcutaneous Allergy Immunotherapies market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Subcutaneous Allergy Immunotherapies market opportunities vary by end market size?
How does Subcutaneous Allergy Immunotherapies break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Subcutaneous Allergy Immunotherapies Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Subcutaneous Allergy Immunotherapies by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Subcutaneous Allergy Immunotherapies by Country/Region, 2018, 2022 & 2029
2.2 Subcutaneous Allergy Immunotherapies Segment by Type
2.2.1 High Concentration
2.2.2 Low Concentration
2.3 Subcutaneous Allergy Immunotherapies Sales by Type
2.3.1 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2018-2023)
2.3.2 Global Subcutaneous Allergy Immunotherapies Revenue and Market Share by Type (2018-2023)
2.3.3 Global Subcutaneous Allergy Immunotherapies Sale Price by Type (2018-2023)
2.4 Subcutaneous Allergy Immunotherapies Segment by Application
2.4.1 Primary Immunodeficiency
2.4.2 Secondary Immunodeficiency
2.4.3 Others
2.5 Subcutaneous Allergy Immunotherapies Sales by Application
2.5.1 Global Subcutaneous Allergy Immunotherapies Sale Market Share by Application (2018-2023)
2.5.2 Global Subcutaneous Allergy Immunotherapies Revenue and Market Share by Application (2018-2023)
2.5.3 Global Subcutaneous Allergy Immunotherapies Sale Price by Application (2018-2023)
3 GLOBAL SUBCUTANEOUS ALLERGY IMMUNOTHERAPIES BY COMPANY
3.1 Global Subcutaneous Allergy Immunotherapies Breakdown Data by Company
3.1.1 Global Subcutaneous Allergy Immunotherapies Annual Sales by Company (2018-2023)
3.1.2 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Company (2018-2023)
3.2 Global Subcutaneous Allergy Immunotherapies Annual Revenue by Company (2018-2023)
3.2.1 Global Subcutaneous Allergy Immunotherapies Revenue by Company (2018-2023)
3.2.2 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Company (2018-2023)
3.3 Global Subcutaneous Allergy Immunotherapies Sale Price by Company
3.4 Key Manufacturers Subcutaneous Allergy Immunotherapies Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Subcutaneous Allergy Immunotherapies Product Location Distribution
3.4.2 Players Subcutaneous Allergy Immunotherapies Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SUBCUTANEOUS ALLERGY IMMUNOTHERAPIES BY GEOGRAPHIC REGION
4.1 World Historic Subcutaneous Allergy Immunotherapies Market Size by Geographic Region (2018-2023)
4.1.1 Global Subcutaneous Allergy Immunotherapies Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Subcutaneous Allergy Immunotherapies Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Subcutaneous Allergy Immunotherapies Market Size by Country/Region (2018-2023)
4.2.1 Global Subcutaneous Allergy Immunotherapies Annual Sales by Country/Region (2018-2023)
4.2.2 Global Subcutaneous Allergy Immunotherapies Annual Revenue by Country/Region (2018-2023)
4.3 Americas Subcutaneous Allergy Immunotherapies Sales Growth
4.4 APAC Subcutaneous Allergy Immunotherapies Sales Growth
4.5 Europe Subcutaneous Allergy Immunotherapies Sales Growth
4.6 Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Growth
5 AMERICAS
5.1 Americas Subcutaneous Allergy Immunotherapies Sales by Country
5.1.1 Americas Subcutaneous Allergy Immunotherapies Sales by Country (2018-2023)
5.1.2 Americas Subcutaneous Allergy Immunotherapies Revenue by Country (2018-2023)
5.2 Americas Subcutaneous Allergy Immunotherapies Sales by Type
5.3 Americas Subcutaneous Allergy Immunotherapies Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Subcutaneous Allergy Immunotherapies Sales by Region
6.1.1 APAC Subcutaneous Allergy Immunotherapies Sales by Region (2018-2023)
6.1.2 APAC Subcutaneous Allergy Immunotherapies Revenue by Region (2018-2023)
6.2 APAC Subcutaneous Allergy Immunotherapies Sales by Type
6.3 APAC Subcutaneous Allergy Immunotherapies Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Subcutaneous Allergy Immunotherapies by Country
7.1.1 Europe Subcutaneous Allergy Immunotherapies Sales by Country (2018-2023)
7.1.2 Europe Subcutaneous Allergy Immunotherapies Revenue by Country (2018-2023)
7.2 Europe Subcutaneous Allergy Immunotherapies Sales by Type
7.3 Europe Subcutaneous Allergy Immunotherapies Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Subcutaneous Allergy Immunotherapies by Country
8.1.1 Middle East & Africa Subcutaneous Allergy Immunotherapies Sales by Country (2018-2023)
8.1.2 Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue by Country (2018-2023)
8.2 Middle East & Africa Subcutaneous Allergy Immunotherapies Sales by Type
8.3 Middle East & Africa Subcutaneous Allergy Immunotherapies Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Subcutaneous Allergy Immunotherapies
10.3 Manufacturing Process Analysis of Subcutaneous Allergy Immunotherapies
10.4 Industry Chain Structure of Subcutaneous Allergy Immunotherapies
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Subcutaneous Allergy Immunotherapies Distributors
11.3 Subcutaneous Allergy Immunotherapies Customer
12 WORLD FORECAST REVIEW FOR SUBCUTANEOUS ALLERGY IMMUNOTHERAPIES BY GEOGRAPHIC REGION
12.1 Global Subcutaneous Allergy Immunotherapies Market Size Forecast by Region
12.1.1 Global Subcutaneous Allergy Immunotherapies Forecast by Region (2024-2029)
12.1.2 Global Subcutaneous Allergy Immunotherapies Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Subcutaneous Allergy Immunotherapies Forecast by Type
12.7 Global Subcutaneous Allergy Immunotherapies Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 ALK-Abello
13.1.1 ALK-Abello Company Information
13.1.2 ALK-Abello Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
13.1.3 ALK-Abello Subcutaneous Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 ALK-Abello Main Business Overview
13.1.5 ALK-Abello Latest Developments
13.2 Stallergenes Greer
13.2.1 Stallergenes Greer Company Information
13.2.2 Stallergenes Greer Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
13.2.3 Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Stallergenes Greer Main Business Overview
13.2.5 Stallergenes Greer Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
13.3.3 Merck Subcutaneous Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Allergy Therapeutics
13.4.1 Allergy Therapeutics Company Information
13.4.2 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
13.4.3 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Allergy Therapeutics Main Business Overview
13.4.5 Allergy Therapeutics Latest Developments
13.5 HAL
13.5.1 HAL Company Information
13.5.2 HAL Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
13.5.3 HAL Subcutaneous Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 HAL Main Business Overview
13.5.5 HAL Latest Developments
13.6 WOLW Pharma
13.6.1 WOLW Pharma Company Information
13.6.2 WOLW Pharma Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
13.6.3 WOLW Pharma Subcutaneous Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 WOLW Pharma Main Business Overview
13.6.5 WOLW Pharma Latest Developments
13.7 Holister Stier
13.7.1 Holister Stier Company Information
13.7.2 Holister Stier Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
13.7.3 Holister Stier Subcutaneous Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Holister Stier Main Business Overview
13.7.5 Holister Stier Latest Developments
13.8 Leti
13.8.1 Leti Company Information
13.8.2 Leti Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
13.8.3 Leti Subcutaneous Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Leti Main Business Overview
13.8.5 Leti Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Subcutaneous Allergy Immunotherapies Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Subcutaneous Allergy Immunotherapies by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Subcutaneous Allergy Immunotherapies by Country/Region, 2018, 2022 & 2029
2.2 Subcutaneous Allergy Immunotherapies Segment by Type
2.2.1 High Concentration
2.2.2 Low Concentration
2.3 Subcutaneous Allergy Immunotherapies Sales by Type
2.3.1 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2018-2023)
2.3.2 Global Subcutaneous Allergy Immunotherapies Revenue and Market Share by Type (2018-2023)
2.3.3 Global Subcutaneous Allergy Immunotherapies Sale Price by Type (2018-2023)
2.4 Subcutaneous Allergy Immunotherapies Segment by Application
2.4.1 Primary Immunodeficiency
2.4.2 Secondary Immunodeficiency
2.4.3 Others
2.5 Subcutaneous Allergy Immunotherapies Sales by Application
2.5.1 Global Subcutaneous Allergy Immunotherapies Sale Market Share by Application (2018-2023)
2.5.2 Global Subcutaneous Allergy Immunotherapies Revenue and Market Share by Application (2018-2023)
2.5.3 Global Subcutaneous Allergy Immunotherapies Sale Price by Application (2018-2023)
3 GLOBAL SUBCUTANEOUS ALLERGY IMMUNOTHERAPIES BY COMPANY
3.1 Global Subcutaneous Allergy Immunotherapies Breakdown Data by Company
3.1.1 Global Subcutaneous Allergy Immunotherapies Annual Sales by Company (2018-2023)
3.1.2 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Company (2018-2023)
3.2 Global Subcutaneous Allergy Immunotherapies Annual Revenue by Company (2018-2023)
3.2.1 Global Subcutaneous Allergy Immunotherapies Revenue by Company (2018-2023)
3.2.2 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Company (2018-2023)
3.3 Global Subcutaneous Allergy Immunotherapies Sale Price by Company
3.4 Key Manufacturers Subcutaneous Allergy Immunotherapies Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Subcutaneous Allergy Immunotherapies Product Location Distribution
3.4.2 Players Subcutaneous Allergy Immunotherapies Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SUBCUTANEOUS ALLERGY IMMUNOTHERAPIES BY GEOGRAPHIC REGION
4.1 World Historic Subcutaneous Allergy Immunotherapies Market Size by Geographic Region (2018-2023)
4.1.1 Global Subcutaneous Allergy Immunotherapies Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Subcutaneous Allergy Immunotherapies Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Subcutaneous Allergy Immunotherapies Market Size by Country/Region (2018-2023)
4.2.1 Global Subcutaneous Allergy Immunotherapies Annual Sales by Country/Region (2018-2023)
4.2.2 Global Subcutaneous Allergy Immunotherapies Annual Revenue by Country/Region (2018-2023)
4.3 Americas Subcutaneous Allergy Immunotherapies Sales Growth
4.4 APAC Subcutaneous Allergy Immunotherapies Sales Growth
4.5 Europe Subcutaneous Allergy Immunotherapies Sales Growth
4.6 Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Growth
5 AMERICAS
5.1 Americas Subcutaneous Allergy Immunotherapies Sales by Country
5.1.1 Americas Subcutaneous Allergy Immunotherapies Sales by Country (2018-2023)
5.1.2 Americas Subcutaneous Allergy Immunotherapies Revenue by Country (2018-2023)
5.2 Americas Subcutaneous Allergy Immunotherapies Sales by Type
5.3 Americas Subcutaneous Allergy Immunotherapies Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Subcutaneous Allergy Immunotherapies Sales by Region
6.1.1 APAC Subcutaneous Allergy Immunotherapies Sales by Region (2018-2023)
6.1.2 APAC Subcutaneous Allergy Immunotherapies Revenue by Region (2018-2023)
6.2 APAC Subcutaneous Allergy Immunotherapies Sales by Type
6.3 APAC Subcutaneous Allergy Immunotherapies Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Subcutaneous Allergy Immunotherapies by Country
7.1.1 Europe Subcutaneous Allergy Immunotherapies Sales by Country (2018-2023)
7.1.2 Europe Subcutaneous Allergy Immunotherapies Revenue by Country (2018-2023)
7.2 Europe Subcutaneous Allergy Immunotherapies Sales by Type
7.3 Europe Subcutaneous Allergy Immunotherapies Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Subcutaneous Allergy Immunotherapies by Country
8.1.1 Middle East & Africa Subcutaneous Allergy Immunotherapies Sales by Country (2018-2023)
8.1.2 Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue by Country (2018-2023)
8.2 Middle East & Africa Subcutaneous Allergy Immunotherapies Sales by Type
8.3 Middle East & Africa Subcutaneous Allergy Immunotherapies Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Subcutaneous Allergy Immunotherapies
10.3 Manufacturing Process Analysis of Subcutaneous Allergy Immunotherapies
10.4 Industry Chain Structure of Subcutaneous Allergy Immunotherapies
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Subcutaneous Allergy Immunotherapies Distributors
11.3 Subcutaneous Allergy Immunotherapies Customer
12 WORLD FORECAST REVIEW FOR SUBCUTANEOUS ALLERGY IMMUNOTHERAPIES BY GEOGRAPHIC REGION
12.1 Global Subcutaneous Allergy Immunotherapies Market Size Forecast by Region
12.1.1 Global Subcutaneous Allergy Immunotherapies Forecast by Region (2024-2029)
12.1.2 Global Subcutaneous Allergy Immunotherapies Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Subcutaneous Allergy Immunotherapies Forecast by Type
12.7 Global Subcutaneous Allergy Immunotherapies Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 ALK-Abello
13.1.1 ALK-Abello Company Information
13.1.2 ALK-Abello Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
13.1.3 ALK-Abello Subcutaneous Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 ALK-Abello Main Business Overview
13.1.5 ALK-Abello Latest Developments
13.2 Stallergenes Greer
13.2.1 Stallergenes Greer Company Information
13.2.2 Stallergenes Greer Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
13.2.3 Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Stallergenes Greer Main Business Overview
13.2.5 Stallergenes Greer Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
13.3.3 Merck Subcutaneous Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Allergy Therapeutics
13.4.1 Allergy Therapeutics Company Information
13.4.2 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
13.4.3 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Allergy Therapeutics Main Business Overview
13.4.5 Allergy Therapeutics Latest Developments
13.5 HAL
13.5.1 HAL Company Information
13.5.2 HAL Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
13.5.3 HAL Subcutaneous Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 HAL Main Business Overview
13.5.5 HAL Latest Developments
13.6 WOLW Pharma
13.6.1 WOLW Pharma Company Information
13.6.2 WOLW Pharma Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
13.6.3 WOLW Pharma Subcutaneous Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 WOLW Pharma Main Business Overview
13.6.5 WOLW Pharma Latest Developments
13.7 Holister Stier
13.7.1 Holister Stier Company Information
13.7.2 Holister Stier Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
13.7.3 Holister Stier Subcutaneous Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Holister Stier Main Business Overview
13.7.5 Holister Stier Latest Developments
13.8 Leti
13.8.1 Leti Company Information
13.8.2 Leti Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
13.8.3 Leti Subcutaneous Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Leti Main Business Overview
13.8.5 Leti Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Subcutaneous Allergy Immunotherapies Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Subcutaneous Allergy Immunotherapies Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of High Concentration
Table 4. Major Players of Low Concentration
Table 5. Global Subcutaneous Allergy Immunotherapies Sales by Type (2018-2023) & (K Units)
Table 6. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2018-2023)
Table 7. Global Subcutaneous Allergy Immunotherapies Revenue by Type (2018-2023) & ($ million)
Table 8. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2018-2023)
Table 9. Global Subcutaneous Allergy Immunotherapies Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Subcutaneous Allergy Immunotherapies Sales by Application (2018-2023) & (K Units)
Table 11. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2018-2023)
Table 12. Global Subcutaneous Allergy Immunotherapies Revenue by Application (2018-2023)
Table 13. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2018-2023)
Table 14. Global Subcutaneous Allergy Immunotherapies Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Subcutaneous Allergy Immunotherapies Sales by Company (2018-2023) & (K Units)
Table 16. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Company (2018-2023)
Table 17. Global Subcutaneous Allergy Immunotherapies Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Company (2018-2023)
Table 19. Global Subcutaneous Allergy Immunotherapies Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Subcutaneous Allergy Immunotherapies Producing Area Distribution and Sales Area
Table 21. Players Subcutaneous Allergy Immunotherapies Products Offered
Table 22. Subcutaneous Allergy Immunotherapies Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Subcutaneous Allergy Immunotherapies Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Subcutaneous Allergy Immunotherapies Sales Market Share Geographic Region (2018-2023)
Table 27. Global Subcutaneous Allergy Immunotherapies Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Subcutaneous Allergy Immunotherapies Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Country/Region (2018-2023)
Table 31. Global Subcutaneous Allergy Immunotherapies Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Subcutaneous Allergy Immunotherapies Sales by Country (2018-2023) & (K Units)
Table 34. Americas Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2018-2023)
Table 35. Americas Subcutaneous Allergy Immunotherapies Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Subcutaneous Allergy Immunotherapies Revenue Market Share by Country (2018-2023)
Table 37. Americas Subcutaneous Allergy Immunotherapies Sales by Type (2018-2023) & (K Units)
Table 38. Americas Subcutaneous Allergy Immunotherapies Sales by Application (2018-2023) & (K Units)
Table 39. APAC Subcutaneous Allergy Immunotherapies Sales by Region (2018-2023) & (K Units)
Table 40. APAC Subcutaneous Allergy Immunotherapies Sales Market Share by Region (2018-2023)
Table 41. APAC Subcutaneous Allergy Immunotherapies Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Subcutaneous Allergy Immunotherapies Revenue Market Share by Region (2018-2023)
Table 43. APAC Subcutaneous Allergy Immunotherapies Sales by Type (2018-2023) & (K Units)
Table 44. APAC Subcutaneous Allergy Immunotherapies Sales by Application (2018-2023) & (K Units)
Table 45. Europe Subcutaneous Allergy Immunotherapies Sales by Country (2018-2023) & (K Units)
Table 46. Europe Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2018-2023)
Table 47. Europe Subcutaneous Allergy Immunotherapies Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Subcutaneous Allergy Immunotherapies Revenue Market Share by Country (2018-2023)
Table 49. Europe Subcutaneous Allergy Immunotherapies Sales by Type (2018-2023) & (K Units)
Table 50. Europe Subcutaneous Allergy Immunotherapies Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Subcutaneous Allergy Immunotherapies
Table 58. Key Market Challenges & Risks of Subcutaneous Allergy Immunotherapies
Table 59. Key Industry Trends of Subcutaneous Allergy Immunotherapies
Table 60. Subcutaneous Allergy Immunotherapies Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Subcutaneous Allergy Immunotherapies Distributors List
Table 63. Subcutaneous Allergy Immunotherapies Customer List
Table 64. Global Subcutaneous Allergy Immunotherapies Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Subcutaneous Allergy Immunotherapies Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Subcutaneous Allergy Immunotherapies Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Subcutaneous Allergy Immunotherapies Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Subcutaneous Allergy Immunotherapies Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Subcutaneous Allergy Immunotherapies Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Subcutaneous Allergy Immunotherapies Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Subcutaneous Allergy Immunotherapies Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Subcutaneous Allergy Immunotherapies Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Subcutaneous Allergy Immunotherapies Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Subcutaneous Allergy Immunotherapies Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Subcutaneous Allergy Immunotherapies Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. ALK-Abello Basic Information, Subcutaneous Allergy Immunotherapies Manufacturing Base, Sales Area and Its Competitors
Table 79. ALK-Abello Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
Table 80. ALK-Abello Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. ALK-Abello Main Business
Table 82. ALK-Abello Latest Developments
Table 83. Stallergenes Greer Basic Information, Subcutaneous Allergy Immunotherapies Manufacturing Base, Sales Area and Its Competitors
Table 84. Stallergenes Greer Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
Table 85. Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Stallergenes Greer Main Business
Table 87. Stallergenes Greer Latest Developments
Table 88. Merck Basic Information, Subcutaneous Allergy Immunotherapies Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
Table 90. Merck Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Merck Main Business
Table 92. Merck Latest Developments
Table 93. Allergy Therapeutics Basic Information, Subcutaneous Allergy Immunotherapies Manufacturing Base, Sales Area and Its Competitors
Table 94. Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
Table 95. Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Allergy Therapeutics Main Business
Table 97. Allergy Therapeutics Latest Developments
Table 98. HAL Basic Information, Subcutaneous Allergy Immunotherapies Manufacturing Base, Sales Area and Its Competitors
Table 99. HAL Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
Table 100. HAL Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. HAL Main Business
Table 102. HAL Latest Developments
Table 103. WOLW Pharma Basic Information, Subcutaneous Allergy Immunotherapies Manufacturing Base, Sales Area and Its Competitors
Table 104. WOLW Pharma Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
Table 105. WOLW Pharma Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. WOLW Pharma Main Business
Table 107. WOLW Pharma Latest Developments
Table 108. Holister Stier Basic Information, Subcutaneous Allergy Immunotherapies Manufacturing Base, Sales Area and Its Competitors
Table 109. Holister Stier Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
Table 110. Holister Stier Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Holister Stier Main Business
Table 112. Holister Stier Latest Developments
Table 113. Leti Basic Information, Subcutaneous Allergy Immunotherapies Manufacturing Base, Sales Area and Its Competitors
Table 114. Leti Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
Table 115. Leti Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Leti Main Business
Table 117. Leti Latest Developments
Table 1. Subcutaneous Allergy Immunotherapies Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Subcutaneous Allergy Immunotherapies Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of High Concentration
Table 4. Major Players of Low Concentration
Table 5. Global Subcutaneous Allergy Immunotherapies Sales by Type (2018-2023) & (K Units)
Table 6. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2018-2023)
Table 7. Global Subcutaneous Allergy Immunotherapies Revenue by Type (2018-2023) & ($ million)
Table 8. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2018-2023)
Table 9. Global Subcutaneous Allergy Immunotherapies Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Subcutaneous Allergy Immunotherapies Sales by Application (2018-2023) & (K Units)
Table 11. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2018-2023)
Table 12. Global Subcutaneous Allergy Immunotherapies Revenue by Application (2018-2023)
Table 13. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2018-2023)
Table 14. Global Subcutaneous Allergy Immunotherapies Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Subcutaneous Allergy Immunotherapies Sales by Company (2018-2023) & (K Units)
Table 16. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Company (2018-2023)
Table 17. Global Subcutaneous Allergy Immunotherapies Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Company (2018-2023)
Table 19. Global Subcutaneous Allergy Immunotherapies Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Subcutaneous Allergy Immunotherapies Producing Area Distribution and Sales Area
Table 21. Players Subcutaneous Allergy Immunotherapies Products Offered
Table 22. Subcutaneous Allergy Immunotherapies Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Subcutaneous Allergy Immunotherapies Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Subcutaneous Allergy Immunotherapies Sales Market Share Geographic Region (2018-2023)
Table 27. Global Subcutaneous Allergy Immunotherapies Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Subcutaneous Allergy Immunotherapies Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Country/Region (2018-2023)
Table 31. Global Subcutaneous Allergy Immunotherapies Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Subcutaneous Allergy Immunotherapies Sales by Country (2018-2023) & (K Units)
Table 34. Americas Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2018-2023)
Table 35. Americas Subcutaneous Allergy Immunotherapies Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Subcutaneous Allergy Immunotherapies Revenue Market Share by Country (2018-2023)
Table 37. Americas Subcutaneous Allergy Immunotherapies Sales by Type (2018-2023) & (K Units)
Table 38. Americas Subcutaneous Allergy Immunotherapies Sales by Application (2018-2023) & (K Units)
Table 39. APAC Subcutaneous Allergy Immunotherapies Sales by Region (2018-2023) & (K Units)
Table 40. APAC Subcutaneous Allergy Immunotherapies Sales Market Share by Region (2018-2023)
Table 41. APAC Subcutaneous Allergy Immunotherapies Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Subcutaneous Allergy Immunotherapies Revenue Market Share by Region (2018-2023)
Table 43. APAC Subcutaneous Allergy Immunotherapies Sales by Type (2018-2023) & (K Units)
Table 44. APAC Subcutaneous Allergy Immunotherapies Sales by Application (2018-2023) & (K Units)
Table 45. Europe Subcutaneous Allergy Immunotherapies Sales by Country (2018-2023) & (K Units)
Table 46. Europe Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2018-2023)
Table 47. Europe Subcutaneous Allergy Immunotherapies Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Subcutaneous Allergy Immunotherapies Revenue Market Share by Country (2018-2023)
Table 49. Europe Subcutaneous Allergy Immunotherapies Sales by Type (2018-2023) & (K Units)
Table 50. Europe Subcutaneous Allergy Immunotherapies Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Subcutaneous Allergy Immunotherapies
Table 58. Key Market Challenges & Risks of Subcutaneous Allergy Immunotherapies
Table 59. Key Industry Trends of Subcutaneous Allergy Immunotherapies
Table 60. Subcutaneous Allergy Immunotherapies Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Subcutaneous Allergy Immunotherapies Distributors List
Table 63. Subcutaneous Allergy Immunotherapies Customer List
Table 64. Global Subcutaneous Allergy Immunotherapies Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Subcutaneous Allergy Immunotherapies Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Subcutaneous Allergy Immunotherapies Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Subcutaneous Allergy Immunotherapies Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Subcutaneous Allergy Immunotherapies Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Subcutaneous Allergy Immunotherapies Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Subcutaneous Allergy Immunotherapies Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Subcutaneous Allergy Immunotherapies Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Subcutaneous Allergy Immunotherapies Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Subcutaneous Allergy Immunotherapies Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Subcutaneous Allergy Immunotherapies Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Subcutaneous Allergy Immunotherapies Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. ALK-Abello Basic Information, Subcutaneous Allergy Immunotherapies Manufacturing Base, Sales Area and Its Competitors
Table 79. ALK-Abello Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
Table 80. ALK-Abello Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. ALK-Abello Main Business
Table 82. ALK-Abello Latest Developments
Table 83. Stallergenes Greer Basic Information, Subcutaneous Allergy Immunotherapies Manufacturing Base, Sales Area and Its Competitors
Table 84. Stallergenes Greer Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
Table 85. Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Stallergenes Greer Main Business
Table 87. Stallergenes Greer Latest Developments
Table 88. Merck Basic Information, Subcutaneous Allergy Immunotherapies Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
Table 90. Merck Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Merck Main Business
Table 92. Merck Latest Developments
Table 93. Allergy Therapeutics Basic Information, Subcutaneous Allergy Immunotherapies Manufacturing Base, Sales Area and Its Competitors
Table 94. Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
Table 95. Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Allergy Therapeutics Main Business
Table 97. Allergy Therapeutics Latest Developments
Table 98. HAL Basic Information, Subcutaneous Allergy Immunotherapies Manufacturing Base, Sales Area and Its Competitors
Table 99. HAL Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
Table 100. HAL Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. HAL Main Business
Table 102. HAL Latest Developments
Table 103. WOLW Pharma Basic Information, Subcutaneous Allergy Immunotherapies Manufacturing Base, Sales Area and Its Competitors
Table 104. WOLW Pharma Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
Table 105. WOLW Pharma Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. WOLW Pharma Main Business
Table 107. WOLW Pharma Latest Developments
Table 108. Holister Stier Basic Information, Subcutaneous Allergy Immunotherapies Manufacturing Base, Sales Area and Its Competitors
Table 109. Holister Stier Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
Table 110. Holister Stier Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Holister Stier Main Business
Table 112. Holister Stier Latest Developments
Table 113. Leti Basic Information, Subcutaneous Allergy Immunotherapies Manufacturing Base, Sales Area and Its Competitors
Table 114. Leti Subcutaneous Allergy Immunotherapies Product Portfolios and Specifications
Table 115. Leti Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Leti Main Business
Table 117. Leti Latest Developments
LIST OF FIGURES
Figure 1. Picture of Subcutaneous Allergy Immunotherapies
Figure 2. Subcutaneous Allergy Immunotherapies Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Subcutaneous Allergy Immunotherapies Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Subcutaneous Allergy Immunotherapies Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Subcutaneous Allergy Immunotherapies Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of High Concentration
Figure 10. Product Picture of Low Concentration
Figure 11. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type in 2022
Figure 12. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2018-2023)
Figure 13. Subcutaneous Allergy Immunotherapies Consumed in Primary Immunodeficiency
Figure 14. Global Subcutaneous Allergy Immunotherapies Market: Primary Immunodeficiency (2018-2023) & (K Units)
Figure 15. Subcutaneous Allergy Immunotherapies Consumed in Secondary Immunodeficiency
Figure 16. Global Subcutaneous Allergy Immunotherapies Market: Secondary Immunodeficiency (2018-2023) & (K Units)
Figure 17. Subcutaneous Allergy Immunotherapies Consumed in Others
Figure 18. Global Subcutaneous Allergy Immunotherapies Market: Others (2018-2023) & (K Units)
Figure 19. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2022)
Figure 20. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application in 2022
Figure 21. Subcutaneous Allergy Immunotherapies Sales Market by Company in 2022 (K Units)
Figure 22. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Company in 2022
Figure 23. Subcutaneous Allergy Immunotherapies Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Company in 2022
Figure 25. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Subcutaneous Allergy Immunotherapies Sales 2018-2023 (K Units)
Figure 28. Americas Subcutaneous Allergy Immunotherapies Revenue 2018-2023 ($ Millions)
Figure 29. APAC Subcutaneous Allergy Immunotherapies Sales 2018-2023 (K Units)
Figure 30. APAC Subcutaneous Allergy Immunotherapies Revenue 2018-2023 ($ Millions)
Figure 31. Europe Subcutaneous Allergy Immunotherapies Sales 2018-2023 (K Units)
Figure 32. Europe Subcutaneous Allergy Immunotherapies Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue 2018-2023 ($ Millions)
Figure 35. Americas Subcutaneous Allergy Immunotherapies Sales Market Share by Country in 2022
Figure 36. Americas Subcutaneous Allergy Immunotherapies Revenue Market Share by Country in 2022
Figure 37. Americas Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2018-2023)
Figure 38. Americas Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2018-2023)
Figure 39. United States Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Subcutaneous Allergy Immunotherapies Sales Market Share by Region in 2022
Figure 44. APAC Subcutaneous Allergy Immunotherapies Revenue Market Share by Regions in 2022
Figure 45. APAC Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2018-2023)
Figure 46. APAC Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2018-2023)
Figure 47. China Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Subcutaneous Allergy Immunotherapies Sales Market Share by Country in 2022
Figure 55. Europe Subcutaneous Allergy Immunotherapies Revenue Market Share by Country in 2022
Figure 56. Europe Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2018-2023)
Figure 57. Europe Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2018-2023)
Figure 58. Germany Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2018-2023)
Figure 67. Egypt Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Subcutaneous Allergy Immunotherapies in 2022
Figure 73. Manufacturing Process Analysis of Subcutaneous Allergy Immunotherapies
Figure 74. Industry Chain Structure of Subcutaneous Allergy Immunotherapies
Figure 75. Channels of Distribution
Figure 76. Global Subcutaneous Allergy Immunotherapies Sales Market Forecast by Region (2024-2029)
Figure 77. Global Subcutaneous Allergy Immunotherapies Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Subcutaneous Allergy Immunotherapies Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Subcutaneous Allergy Immunotherapies Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Subcutaneous Allergy Immunotherapies Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Subcutaneous Allergy Immunotherapies Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Subcutaneous Allergy Immunotherapies
Figure 2. Subcutaneous Allergy Immunotherapies Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Subcutaneous Allergy Immunotherapies Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Subcutaneous Allergy Immunotherapies Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Subcutaneous Allergy Immunotherapies Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of High Concentration
Figure 10. Product Picture of Low Concentration
Figure 11. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type in 2022
Figure 12. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2018-2023)
Figure 13. Subcutaneous Allergy Immunotherapies Consumed in Primary Immunodeficiency
Figure 14. Global Subcutaneous Allergy Immunotherapies Market: Primary Immunodeficiency (2018-2023) & (K Units)
Figure 15. Subcutaneous Allergy Immunotherapies Consumed in Secondary Immunodeficiency
Figure 16. Global Subcutaneous Allergy Immunotherapies Market: Secondary Immunodeficiency (2018-2023) & (K Units)
Figure 17. Subcutaneous Allergy Immunotherapies Consumed in Others
Figure 18. Global Subcutaneous Allergy Immunotherapies Market: Others (2018-2023) & (K Units)
Figure 19. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2022)
Figure 20. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application in 2022
Figure 21. Subcutaneous Allergy Immunotherapies Sales Market by Company in 2022 (K Units)
Figure 22. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Company in 2022
Figure 23. Subcutaneous Allergy Immunotherapies Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Company in 2022
Figure 25. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Subcutaneous Allergy Immunotherapies Sales 2018-2023 (K Units)
Figure 28. Americas Subcutaneous Allergy Immunotherapies Revenue 2018-2023 ($ Millions)
Figure 29. APAC Subcutaneous Allergy Immunotherapies Sales 2018-2023 (K Units)
Figure 30. APAC Subcutaneous Allergy Immunotherapies Revenue 2018-2023 ($ Millions)
Figure 31. Europe Subcutaneous Allergy Immunotherapies Sales 2018-2023 (K Units)
Figure 32. Europe Subcutaneous Allergy Immunotherapies Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue 2018-2023 ($ Millions)
Figure 35. Americas Subcutaneous Allergy Immunotherapies Sales Market Share by Country in 2022
Figure 36. Americas Subcutaneous Allergy Immunotherapies Revenue Market Share by Country in 2022
Figure 37. Americas Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2018-2023)
Figure 38. Americas Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2018-2023)
Figure 39. United States Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Subcutaneous Allergy Immunotherapies Sales Market Share by Region in 2022
Figure 44. APAC Subcutaneous Allergy Immunotherapies Revenue Market Share by Regions in 2022
Figure 45. APAC Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2018-2023)
Figure 46. APAC Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2018-2023)
Figure 47. China Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Subcutaneous Allergy Immunotherapies Sales Market Share by Country in 2022
Figure 55. Europe Subcutaneous Allergy Immunotherapies Revenue Market Share by Country in 2022
Figure 56. Europe Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2018-2023)
Figure 57. Europe Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2018-2023)
Figure 58. Germany Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Subcutaneous Allergy Immunotherapies Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2018-2023)
Figure 67. Egypt Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Subcutaneous Allergy Immunotherapies Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Subcutaneous Allergy Immunotherapies in 2022
Figure 73. Manufacturing Process Analysis of Subcutaneous Allergy Immunotherapies
Figure 74. Industry Chain Structure of Subcutaneous Allergy Immunotherapies
Figure 75. Channels of Distribution
Figure 76. Global Subcutaneous Allergy Immunotherapies Sales Market Forecast by Region (2024-2029)
Figure 77. Global Subcutaneous Allergy Immunotherapies Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Subcutaneous Allergy Immunotherapies Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Subcutaneous Allergy Immunotherapies Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Subcutaneous Allergy Immunotherapies Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Subcutaneous Allergy Immunotherapies Revenue Market Share Forecast by Application (2024-2029)
